Skip to content

Monitor TTR (Transthyretin) indexes in blood of patients with post-stroke cognitive impairment (PSCI)

Monitor TTR (Transthyretin) indexes in blood of patients with post-stroke cognitive impairment (PSCI)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020839
Enrollment
Unknown
Registered
2019-01-20
Start date
2019-01-16
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke cognitive impairment

Interventions

PSCI:None
nPSCI:None

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) patients diagnosed with acute ischemic stroke within three months after the first onset (it refers to the ischemic necrosis or softening of local brain tissue caused by cerebral blood circulation disorder, ischemia and hypoxia for the first time); (2) aged 18-65 years old, male or female; (3) sign the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: (1) before the onset of stroke, there was a clear cognitive impairment; (2) participated in any clinical research related to cognitive dysfunction within 2 months before enrollment; (3) those with hearing, vision, language and consciousness disorders that cannot be tested by the scale; (4) patients diagnosed with Parkinson's disease, dementia or other neurodegenerative diseases; (5) patients with thyroid gland related diseases; (6) malnutrition to cachexia; (7) coma after stroke; (8) patients with posterior circulation infarction or other infarcts that can directly damage the hippocampus; (9) patients with emotional disorder after stroke; (10) the patient may be unable to complete this study due to his/her reasons, or the investigator may consider that the patient is not suitable for this study.

Design outcomes

Primary

MeasureTime frame
Transthyretin;

Countries

China

Contacts

Public ContactZhang Yongbo

Beijing Friendship Hospital, Capital Medical University

ybzhangcn@sina.com+86 18811695881

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026